These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 22893596)

  • 1. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
    Khorana AA; Dalal M; Lin J; Connolly GC
    Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer.
    Connolly GC; Dalal M; Lin J; Khorana AA
    Lung Cancer; 2012 Dec; 78(3):253-8. PubMed ID: 23026639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of venous thromboembolism occurrence in medical patients among the insured population.
    Spyropoulos AC; Hussein M; Lin J; Battleman D
    Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
    Khorana AA; Francis CW; Culakova E; Lyman GH
    Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients.
    Ferroni P; Martini F; Portarena I; Massimiani G; Riondino S; La Farina F; Mariotti S; Guadagni F; Roselli M
    Clin Lung Cancer; 2012 Nov; 13(6):482-7. PubMed ID: 22591606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study.
    Scannapieco G; Ageno W; Airoldi A; Bonizzoni E; Campanini M; Gussoni G; Silingardi M; Valerio A; Zilli C; Iori I;
    Thromb Haemost; 2010 Oct; 104(4):734-40. PubMed ID: 20664897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials.
    Hicks LK; Cheung MC; Ding K; Hasan B; Seymour L; Le Maître A; Leighl NB; Shepherd FA
    Cancer; 2009 Dec; 115(23):5516-25. PubMed ID: 19711465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgery.
    Rollins KE; Peters CJ; Safranek PM; Ford H; Baglin TP; Hardwick RH
    Eur J Surg Oncol; 2011 Dec; 37(12):1072-7. PubMed ID: 21925829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics.
    Paneesha S; McManus A; Arya R; Scriven N; Farren T; Nokes T; Bacon S; Nieland A; Cooper D; Smith H; O'Shaughnessy D; Rose P;
    Thromb Haemost; 2010 Feb; 103(2):338-43. PubMed ID: 20024496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system.
    Yu YB; Gau JP; Liu CY; Yang MH; Chiang SC; Hsu HC; Hong YC; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Lee TS; Chou LF; Tzeng CH; Chen TJ
    Thromb Haemost; 2012 Aug; 108(2):225-35. PubMed ID: 22534880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ahlbrecht J; Dickmann B; Ay C; Dunkler D; Thaler J; Schmidinger M; Quehenberger P; Haitel A; Zielinski C; Pabinger I
    J Clin Oncol; 2012 Nov; 30(31):3870-5. PubMed ID: 23008313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative venous thromboembolism predicts survival in cancer patients.
    Auer RA; Scheer AS; McSparron JI; Schulman AR; Tuorto S; Doucette S; Gonsalves J; Fong Y
    Ann Surg; 2012 May; 255(5):963-70. PubMed ID: 22504195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon.
    Otten HM; Mathijssen J; ten Cate H; Soesan M; Inghels M; Richel DJ; Prins MH
    Arch Intern Med; 2004 Jan; 164(2):190-4. PubMed ID: 14744843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE.
    Yhim HY; Jang MJ; Kwak JY; Yim CY; Choi WI; Lee YC; Lee JO; Lee KW; Bang SM; Kim SH; Kim YK; Chang HJ; Oh D;
    Thromb Res; 2013 Apr; 131(4):e133-40. PubMed ID: 23399441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.
    Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
    J Med Econ; 2011; 14(3):324-34. PubMed ID: 21506632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer.
    Sandhu R; Pan CX; Wun T; Harvey D; Zhou H; White RH; Chew HK
    Cancer; 2010 Jun; 116(11):2596-603. PubMed ID: 20336780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
    Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
    Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frequency of venous thromboembolism among hospitalized patients with cancer].
    Conte G; Figueroa G
    Rev Med Chil; 2008 Dec; 136(12):1528-34. PubMed ID: 19350169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients.
    Piran S; Ngo V; McDiarmid S; Le Gal G; Petrcich W; Carrier M
    Thromb Res; 2014 Jan; 133(1):30-3. PubMed ID: 24188799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.